Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Last Name

Contact Us
If you have any questions or feedback please contact us.



This is a "connection" page, showing publications co-authored by Larry Allen and Kelsey Flint.

Connection Strength
  1. Flint K, Chaussee EL, Henderson K, Breathett K, Khazanie P, Thompson JS, Mcilvennan CK, Larue SJ, Matlock DD, Allen LA. Social Determinants of Health and Rates of Implantation for Patients Considering Destination Therapy Left Ventricular Assist Device. J Card Fail. 2021 04; 27(4):497-500.
    View in: PubMed
    Score: 0.794
  2. Flint KM, Spertus JA, Tang F, Jones P, Fendler TJ, Allen LA. Association of global and disease-specific health status with outcomes following continuous-flow left ventricular assist device implantation. BMC Cardiovasc Disord. 2017 03 14; 17(1):78.
    View in: PubMed
    Score: 0.612
  3. Flint KM, Allen LA. Getting a grip on frailty: handgrip strength in patient selection for left ventricular assist device. J Card Fail. 2014 May; 20(5):316-8.
    View in: PubMed
    Score: 0.497
  4. Flint KM, Matlock DD, Sundareswaran KS, Lindenfeld J, Spertus JA, Farrar DJ, Allen LA. Pre-operative health status and outcomes after continuous-flow left ventricular assist device implantation. J Heart Lung Transplant. 2013 Dec; 32(12):1249-54.
    View in: PubMed
    Score: 0.482
  5. Flint KM, Matlock DD, Lindenfeld J, Allen LA. Frailty and the selection of patients for destination therapy left ventricular assist device. Circ Heart Fail. 2012 Mar 01; 5(2):286-93.
    View in: PubMed
    Score: 0.432
  6. Flint KM, Schmiege SJ, Allen LA, Fendler TJ, Rumsfeld J, Bekelman D. Health Status Trajectories Among Outpatients With Heart?Failure. J Pain Symptom Manage. 2017 02; 53(2):224-231.
    View in: PubMed
    Score: 0.149
  7. Flint KM, Allen LA, Pham M, Heidenreich PA. B-type natriuretic peptide predicts 30-day readmission for heart failure but not readmission for other causes. J Am Heart Assoc. 2014 Jun 10; 3(3):e000806.
    View in: PubMed
    Score: 0.126
  8. Wohlfahrt P, Zickmund SL, Slager S, Allen LA, Nicolau JN, Kfoury AG, Felker GM, Conte J, Flint K, DeVore AD, Selzman CH, Hess R, Spertus JA, Stehlik J. Provider Perspectives on the Feasibility and Utility of Routine Patient-Reported Outcomes Assessment in Heart Failure: A Qualitative Analysis. J Am Heart Assoc. 2020 01 21; 9(2):e013047.
    View in: PubMed
    Score: 0.047
  9. Warraich HJ, Allen LA, Blue LJ, Chaussee EL, Thompson JS, McIlvennan CK, Flint KM, Matlock DD, Patel CB. Comorbidities and the decision to undergo or forego destination therapy left ventricular assist device implantation: An analysis from the Trial of a Shared Decision Support Intervention for Patients and their Caregivers Offered Destination Therapy for End-Stage Heart Failure (DECIDE-LVAD) study. Am Heart J. 2019 07; 213:91-96.
    View in: PubMed
    Score: 0.044
  10. Fendler TJ, Spertus JA, Gosch KL, Jones PG, Bruce JM, Nassif ME, Flint KM, Dunlay SM, Allen LA, Arnold SV. Incidence and predictors of cognitive decline in patients with left ventricular assist devices. Circ Cardiovasc Qual Outcomes. 2015 May; 8(3):285-91.
    View in: PubMed
    Score: 0.034
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2024 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)